Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
November 15, 2022
Impact of Mepolizumab on Exacerbations in the US Medicare Population
Sanjay Sethi, Michael Bogart, Thomas Corbridge, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
October 25, 2024
Eosinophil count testing in patients with asthma varies by healthcare provider type in the US: a retrospective study
Sameer Mathur, Thomas Corbridge, Elizabeth Packnett, et al.
Current Opinion in Pulmonary Medicine
|
April 20, 2016
Complications of thoracentesis: incidence, risk factors, and strategies for prevention
Eric P Cantey, James M Walter, Thomas Corbridge, et al.
Annals of the American Thoracic Society
|
March 11, 2016
Acute Hypoxemic Respiratory Failure after Large-Volume Thoracentesis. Mechanisms of Pleural Fluid Formation and Reexpansion Pulmonary Edema
James M Walter, Michael A Matthay, Colin T Gillespie, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 6, 2024
Targeting Asthma Remission as the Next Therapeutic Step Toward Improving Disease Control
William W Busse, Geoffrey Chupp, Thomas Corbridge, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
July 19, 2022
Impact of mepolizumab in patients with high-burden severe asthma within a managed care population
Njira L Lugogo, Michael Bogart, Thomas Corbridge, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
January 9, 2025
Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retrospective analysis
Wendy C Moore, Alexandra Stach-Klysh, Thomas Corbridge, et al.
Advances in Therapy
|
December 24, 2025
Challenges in Evaluating Clinical Remission in Severe Asthma: Insights from the Mayo Clinic
Kaiser Lim, Arijita Deb, Thomas Corbridge, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
March 27, 2024
Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma
Thomas B Casale, Thomas Corbridge, Guillaume Germain, et al.
Proceedings of the American Thoracic Society
|
August 18, 2009
Introduction
Michael Schatz, Amin Antoine Nabih Kazzi, Barry Brenner, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The Journal of Allergy and Clinical Immunology. in Practice
|
November 15, 2022
Impact of Mepolizumab on Exacerbations in the US Medicare Population
Sanjay Sethi, Michael Bogart, Thomas Corbridge, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
October 25, 2024
Eosinophil count testing in patients with asthma varies by healthcare provider type in the US: a retrospective study
Sameer Mathur, Thomas Corbridge, Elizabeth Packnett, et al.
Current Opinion in Pulmonary Medicine
|
April 20, 2016
Complications of thoracentesis: incidence, risk factors, and strategies for prevention
Eric P Cantey, James M Walter, Thomas Corbridge, et al.
Annals of the American Thoracic Society
|
March 11, 2016
Acute Hypoxemic Respiratory Failure after Large-Volume Thoracentesis. Mechanisms of Pleural Fluid Formation and Reexpansion Pulmonary Edema
James M Walter, Michael A Matthay, Colin T Gillespie, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 6, 2024
Targeting Asthma Remission as the Next Therapeutic Step Toward Improving Disease Control
William W Busse, Geoffrey Chupp, Thomas Corbridge, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
July 19, 2022
Impact of mepolizumab in patients with high-burden severe asthma within a managed care population
Njira L Lugogo, Michael Bogart, Thomas Corbridge, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
January 9, 2025
Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retrospective analysis
Wendy C Moore, Alexandra Stach-Klysh, Thomas Corbridge, et al.
Advances in Therapy
|
December 24, 2025
Challenges in Evaluating Clinical Remission in Severe Asthma: Insights from the Mayo Clinic
Kaiser Lim, Arijita Deb, Thomas Corbridge, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
March 27, 2024
Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma
Thomas B Casale, Thomas Corbridge, Guillaume Germain, et al.
Proceedings of the American Thoracic Society
|
August 18, 2009
Introduction
Michael Schatz, Amin Antoine Nabih Kazzi, Barry Brenner, et al.
Page
of 3